1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis award supports projects involving human subjects or samples that will develop and test new hypotheses and/or methods in research areas relevant to cystic fibrosis.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: The Clinical Pilot and Feasibility Award is offered to support projects involving human subjects (see 45 CFR§46. Confirm the full requirements in the official notice before applying.
The current listing shows up to $80,000 per year (plus 12% indirect costs) for single-center studies; up to $150,000 per year (plus 12% indirect costs) for multi-center studies; up to an additional $100,000 in supplemental funding. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Clinical Pilot and Feasibility Award is funded by Cystic Fibrosis Foundation. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) is sponsored by Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) and Neuroendocrine Tumor Research Foundation (NETRF). This grant supports early-career basic or clinical scientists to conduct novel and innovative research in nuclear medicine related to neuroendocrine tumors, with the aim of generating preliminary data for further funding.
HCU Global Grants Program is sponsored by HCU Network America. HCU Network America provides research grants to support novel proposals for the treatment and prevention of clinical manifestations for Classical Homocystinuria and/or Cobalamin G, a Methionine Synthase deficiency. These grants are intended to support innovative seed or pilot projects to produce preliminary data that would facilitate more substantial funding from federal agencies, foundations, or corporations. An Expression of Interest (EOI) was due May 31, 2026, with full applications due August 31, 2026, and funding decisions by October 31, 2026.